Jill Gilbert
- Otorhinolaryngology top 0.2%
- Head and Neck Cancer Studies 40
- Oncology top 1%
- Cancer Diagnosis and Treatment 10
- Peptidase Inhibition and Analysis 9
- Cancer Immunotherapy and Biomarkers 8
- Lung Cancer Research Studies 8
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 6
-
- Lung Cancer Treatments and Mutations 20
- Oral health in cancer treatment 13
- Speech and Hearing top 1%
- Co-authors
- Barbara A. MurphyAnthony J. CmelakSheila H. RidnerChristine H. ChungAugusto C. OchoaJovanny ZabaletaPaulo C. Rodrı́guezSteven M. Dubinett
- Journals
- Journal of Clinical Oncology (28 papers)Clinical Cancer Research (7 papers)Head & Neck (7 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Jill Gilbert
90 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Otorhinolaryngology 1.3k
- Oncology 2.1k
- Cancer Research 568
- Pulmonary and Respiratory Medicine 1.2k
- Speech and Hearing 233
Countries citing papers authored by Jill Gilbert
This map shows the geographic impact of Jill Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Gilbert more than expected).
Fields of papers citing papers by Jill Gilbert
This network shows the impact of papers produced by Jill Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Gilbert. The network helps show where Jill Gilbert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jill Gilbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2020 | 26 | |
| 3 | 2019 | 148 | |
| 4 | 2018 | 14 | |
| 5 | Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Studybreakdown → | 2017 | 497 |
| 6 | E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Groupbreakdown → | 2017 | 317 |
| 7 | 2017 | 28 | |
| 8 | 2016 | 20 | |
| 9 | 2015 | 84 | |
| 10 | 2014 | 78 | |
| 11 | 2013 | 2 | |
| 12 | 2012 | 120 | |
| 13 | 2012 | 30 | |
| 14 | 2011 | 14 | |
| 15 | 2010 | 51 | |
| 16 | 2010 | 125 | |
| 17 | 2008 | 19 | |
| 18 | 2007 | 69 | |
| 19 | 2005 | 46 | |
| 20 | 2004 | 28 |
About Jill Gilbert
Jill Gilbert is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine, having authored 91 papers that have together received 4.5k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (40 papers), Lung Cancer Treatments and Mutations (20 papers), Oral health in cancer treatment (13 papers), Cancer Diagnosis and Treatment (10 papers), Peptidase Inhibition and Analysis (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Research Studies (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). The work is most often cited by research in Otorhinolaryngology (1.3k citations), Oncology (2.1k citations) and Cancer Research (568 citations). Jill Gilbert has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Barbara A. Murphy, Barbara A. Murphy, Anthony J. Cmelak, Sheila H. Ridner, Christine H. Chung, Augusto C. Ochoa, Jovanny Zabaleta, Paulo C. Rodrı́guez, Steven M. Dubinett and Claudia Patricia Pardo Hernández. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Head & Neck, Oral Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.